EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice

Lucas Rannier Ribeiro Antonino Carvalho iD, Maria Tydén iD, Miho Shimari, Zhengbing Zhuge, Tomas A Schiffer, Matheus Morais de Oliveira Monteiro iD, Jon O Lundberg, Eddie Weitzberg, Daniel C Andersson iD, Bengt Fellström, Mattias Carlström iD

Nutrients · 2024

DOI: 10.3390/nu16234105 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Lucas Rannier Ribeiro Antonino Carvalho und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Karolinska Institutet, 17165 Solna, Sweden. Hauptthemen laut MEDLINE: Metabolic Syndrome, Mice, Inbred C57BL, Disease Models, Animal, Diet, Western. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Research Council, Swedish Heart and Lung Foundation, Stockholm County research grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The prevalence of cardiovascular-kidney-metabolic (CKM) syndrome is increasing rapidly, and cardiovascular complications pose significant risks in individuals with kidney disease and metabolic dysfunction. Understanding the mechanisms of CKM disorders is crucial, as is the discovery of novel preventive treatments. This study aimed to examine the therapeutic effects of a specially formulated nitric oxide-enhancing food additive in a mouse model of CKM syndrome induced by unilateral nephrectomy (UNX) in combination with chronic Western diet (WD) feeding.

Methods

C57BL/6J mice underwent UNX and were fed a WD high in salt, sugar, and fat for 12 weeks, compared to sham-operated mice on standard chow. One group of UNX+WD mice received Flexovital (FLX), a food additive containing extracts of Rhodiola rosea and beetroot, and the amino acids L-arginine and L-citrulline. CKM parameters were assessed both in vivo and ex vivo alongside histological and biochemical analyses.

Results

The UNX+WD mice showed an increase in body fat mass, the fat/lean mass ratio, and adipocyte area, of which most were significantly reduced by FLX. Elevated fasting glucose levels were also reduced by FLX, which tended towards improving glucose clearance. Elevated arterial blood pressure and endothelial dysfunction in UNX+WD mice were significantly reduced by FLX. FLX improved GFR and reduced glomerular and tubular injuries in UNX+WD mice. Additionally, FLX increased the P/O ratios of oxidative phosphorylation in the isolated renal mitochondria of UNX+WD mice.

Conclusions

In this model of CKM syndrome, FLX effectively prevented the onset and progression of CKM dysfunctions induced by UNX+WD, as well as the associated organ injuries. These promising results highlight the need for validation in upcoming human trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeMice, Inbred C57BLDisease Models, AnimalDiet, WesternDietary SupplementsAnimalsMiceMaleArginineKidneyCardio-Renal SyndromeNephrectomyCitrullinePlant ExtractsNitric Oxide

Stichwörter der Autor:innen

Rhodiola roseaargininebeetrootcardiovascular-kidney-metabolic syndromecitrullinefood supplementation

Substanzen

ArginineCitrullinePlant ExtractsNitric Oxide

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Karolinska Institutet, 17165 Solna, Sweden.
  • Department of Medical Sciences, Nephrology, Uppsala University, 75236 Uppsala, Sweden.
  • Cardiology Unit, Theme for Heart, Vascular and Neuro, Karolinska University Hospital, 17164 Stockholm, Sweden.

ORCID-Profile: Lucas Rannier Ribeiro Antonino Carvalho, Maria Tydén, Matheus Morais de Oliveira Monteiro, Daniel C Andersson, Mattias Carlström

Förderung

  • Swedish Research Council
  • Swedish Heart and Lung Foundation
  • Stockholm County research grant
  • NovoNordisk
  • Karolinska Institutet

Zitieren

APA

Carvalho, L. R. R. A., Tydén, M., Shimari, M., Zhuge, Z., Schiffer, T. A., de Oliveira Monteiro, M. M., Lundberg, J. O., Weitzberg, E., Andersson, D. C., Fellström, B., & Carlström, M. (2024). Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice. Nutrients. https://doi.org/10.3390/nu16234105

Vancouver

Carvalho LRRA, Tydén M, Shimari M, Zhuge Z, Schiffer TA, de Oliveira Monteiro MM, et al. Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice. Nutrients. 2024. doi:10.3390/nu16234105

BibTeX
@article{Carvalho2024,
  author = {Carvalho, Lucas Rannier Ribeiro Antonino and Tydén, Maria and Shimari, Miho and Zhuge, Zhengbing and Schiffer, Tomas A and de Oliveira Monteiro, Matheus Morais and Lundberg, Jon O and Weitzberg, Eddie and Andersson, Daniel C and Fellström, Bengt and Carlström, Mattias},
  title = {Protective Effects of the Food Supplement Flexovital in a Model of Cardiovascular-Kidney-Metabolic Syndrome in Mice},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16234105}
}
Kostenlos starten →